A more recent version of this regulatory record is available. This version is kept only as a historical record. Please see the Record history section for link to the most recent version.

2-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate (Prallethrin)

CAS23031-36-9
EC245-387-9

List details

Active substance data

Substance information page external link [echa.europa.eu]
Product type PT18-Insecticides, acaricides and products to control other arthropods
BAS number 1353
Candidate for substitution Under Assessment
Regulatory Process
  • Review programme substance
Assesment status Initial approval in progress
Assesment sub-status Opinion development by BPC

Approval data

Evaluating competent authority
  • Greece

Other data

Related authorised biocidal products 0
Factsheet URL external link [echa.europa.eu]
RML Id 100.041.246
Inclusion category 0

Related substances

By adding any of the following substances to your watchlist, you would be monitoring this regulatory record and all possible new regulatory records related to that substance.

Related regulatory records

  • Biocidal active substances
    Product type: PT18-Insecticides, acaricides and products to control other arthropods
  • Harmonised classification and labelling (CLP Annex VI) under the name ETOC (prallethrin (ISO); 2-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate)
    Hazard Class and Category Codes: Acute Tox. 3 *: Acute toxicity; Acute Tox. 4 *: Acute toxicity; Aquatic Acute 1: Hazardous to the aquatic environment; Aquatic Chronic 1: Hazardous to the aquatic environment

Record history

The following timeline shows when we detected changes of this regulatory record (the date might slightly differ from the date of the actual change). Additions between versions are hightlighted in green color, red color shows data removed between versions.

July 2, 2019
  • Assesment status: Initial approval in progressInitial application for approval in progress
This version
Add the related substance to your watchlist to monitor this regulatory record.